Search Results
Prescient Therapeutics is developing novel personalised therapies against a range of cancers
Prescient Therapeutics (ASX: PTX) – Webinar Presentation
Prescient Therapeutics Are Developing Game-Changing Cancer Treatments
Prescient Therapeutics tops-up cash reserves to progress innovative cancer therapies
Prescient Therapeutics advances innovative cancer therapies following successful FY 2021
Biotech CEO Explains How Cell Therapy Could Revolutionise Cancer Treatment
Prescient Therapeutics in the burgeoning field of precision cancer medicines | No.2
ShareCafe 'Hidden Gems' Webinar - Prescient Therapeutics ASX:PTX
A diversified portfolio of cancer treatment medicines.
Prescient Therapeutics (ASX: PTX): PTX-100 targeted cell therapy briefing - 2 March 2023
Prescient Therapeutics (ASX: PTX) Investor Briefing - 1 March 2022
Prescient Therapeutics (ASX: PTX) Investor Briefing - 14 September 2022
